Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer’s disease

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396 · see citing works

Phases of Aβ-deposition in the human brain and its relevance for the development of AD

Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · see citing works

2013 Alzheimer's disease facts and figures

Thies, W. H., & Bleiler, L. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.02.003 · Cited by 3,331 · see citing works

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599 · see citing works

The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

Karran, E., Mercken, M., & Strooper, B. D. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3505 · Cited by 2,188 · cited 4× · see citing works

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140 · see citing works

Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · see citing works

Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production

Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757 · see citing works

Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1

Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Pérez‐Tur, J., Hutton, M., Buée, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,453 · see citing works

Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Strittmatter, W. J., Weisgraber, K. H., Huang, D. Y., Dong, L. M., Salvesen, G. S., Pericak-Vance, M., Schmechel, D., Saunders, A. M., Goldgaber, D., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.8098 · Cited by 1,363 · see citing works

Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo

Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265 · see citing works

APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy

Rovelet‐Lecrux, A., Hannequin, D., Raux, G., Meur, N. L., Laquerrière, A., Vital, A., Dumanchin‐Njock, C., Feuillette, S., Brice, A., Vercelletto, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1718 · Cited by 1,249 · see citing works

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

Bu, G. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2620 · Cited by 1,168 · see citing works

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease

Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., & Ikeda, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91092-f · Cited by 1,157 · see citing works

Amyloid Precursor Protein Trafficking, Processing, and Function

Thinakaran, G., & Koo, E. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800019200 · Cited by 1,141 · see citing works

Tau pathology and neurodegeneration

Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133 · see citing works

Imaging β-amyloid burden in aging and dementia

Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104 · see citing works

Neuronal activity regulates the regional vulnerability to amyloid-β deposition

Bero, A. W., Yan, P., Roh, J. H., Cirrito, J. R., Stewart, F. R., Raichle, M. E., Lee, J.-M., & Holtzman, D. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2801 · Cited by 880 · see citing works

Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques

Koffie, R. M., Meyer-Luehmann, M., Hashimoto, T., Adams, K. W., Mielke, M. L., Garcia-Alloza, M., Micheva, K. D., Smith, S. J., Kim, M. L., Lee, V. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811698106 · Cited by 850 · see citing works

Intraneuronal Alzheimer Aβ42 Accumulates in Multivesicular Bodies and Is Associated with Synaptic Pathology

Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706 · see citing works

Identification of normal and pathological aging in prospectively studied nondemented elderly humans

Dickson, D. W., Crystal, H. A., Mattiace, L. A., Masur, D. M., Blau, A. D., Davies, P., Yen, S.-H., & Aronson, M. K. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90027-u · Cited by 643 · see citing works

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides

Koistinaho, M., Lin, S., Wu, X., Esterman, M., Koger, D., Hanson, J., Higgs, R., Liu, F., Malkani, S., Bales, K. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1058 · Cited by 571 · see citing works

Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis

Small, S. A., & Duff, K. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.007 · Cited by 546 · see citing works

Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition

Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., Morris, J. C., Raichle, M. E., & Mintun, M. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010461107 · Cited by 404 · see citing works

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees

Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., Bi, W., Hoge, J. A., Cohen, A. D., Ikonomovic, M. D., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0730-07.2007 · Cited by 389 · see citing works

Phenotype associated with APP duplication in five families

Cabrejo, L., Guyant‐Maréchal, L., Laquerrière, A., Vercelletto, M., Fournière, F. D. L., Thomas-Antérion, C., Verny, C., Letournel, F., Pasquier, F., Vital, A., et al. (2006) · Brain · doi:10.1093/brain/awl237 · Cited by 342 · see citing works

Massive gliosis induced by interleukin‐6 suppresses Aβ deposition <i>in vivo:</i> evidence against inflammation as a driving force for amyloid deposition

Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P. (2010) · The FASEB Journal · doi:10.1096/fj.09-141754 · Cited by 328 · see citing works

Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40

Kumar‐Singh, S., Theuns, J., Broeck, B. V., Pirici, D. N., Vennekens, K., Corsmit, E., Cruts, M., Dermaut, B., Wang, R., & Broeckhoven, C. V. (2006) · Human Mutation · doi:10.1002/humu.20336 · Cited by 320 · see citing works

Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin–1 gene

Larner, A. J., & Doran, M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0019-5 · Cited by 256 · see citing works

Arc/Arg3.1 Regulates an Endosomal Pathway Essential for Activity-Dependent β-Amyloid Generation

Wu, J., Petralia, R. S., Kurushima, H., Patel, H., Jung, M., Volk, L. J., Chowdhury, S., Shepherd, J. D., Dehoff, M. H., Li, Y., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.036 · Cited by 215 · see citing works

Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer’s disease

Ryan, N. S., Keihaninejad, S., Shakespeare, T. J., Lehmann, M., Crutch, S. J., Malone, I. B., Thornton, J. S., Mancini, L., Hyare, H., Yousry, T., et al. (2013) · Brain · doi:10.1093/brain/awt065 · Cited by 205 · see citing works

High Striatal Amyloid β-Peptide Deposition Across Different Autosomal Alzheimer Disease Mutation Types

Villemagne, V. L., Ataka, S., Mizuno, T., Brooks, W. S., Wada, Y., Kondo, M., Jones, G. R., Watanabe, Y., Mulligan, R. S., Nakagawa, M., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.285 · Cited by 171 · see citing works

Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia

Janocko, N. J., Brodersen, K. A., Soto-Ortolaza, A., Ross, O., Liesinger, A. M., Duara, R., Graff-Radford, N., Dickson, D., & Murray, M. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1044-y · Cited by 138 · see citing works

Aβ‐peptide length aid apolipoprotein E genotype in Alzheimer's disease

Gearing, M., Mori, H., & Mirra, S. S. (1996) · Annals of Neurology · doi:10.1002/ana.410390320 · Cited by 120 · see citing works

Differential Incorporation of Tau Isoforms in Alzheimer's Disease

Espinoza, M., de Silva, R., Dickson, D. W., & Davies, P. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14101 · Cited by 119 · see citing works

PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease

Koivunen, J., Verkkoniemi, A., Aalto, S., Paetau, A. E., Ahonen, J.-P., Viitanen, M. H., Någren, K., Rokka, J., Haaparanta‐Solin, M., Kalimo, H., et al. (2008) · Brain · doi:10.1093/brain/awn107 · Cited by 117 · see citing works

Mean age of onset in familial Alzheimer's disease is determined by amyloid beta 42

Duering, M., Grimm, M. O. W., Grimm, H. S., Schröder, J., & Hartmann, T. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.002 · Cited by 98 · see citing works

Preferential deposition of amyloid β protein (Aβ) in the form Aβ40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele

Mann, D. M. A., Iwatsubo, T., Pickering-Brown, S. M., Owen, F., Saido, T. C., & Perry, R. H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13294-8 · Cited by 91 · see citing works

Characteristics of Tau Oligomers

Ren, Y., & Sahara, N. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00102 · Cited by 86 · see citing works

Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers

Knight, W. D., Okello, A., Ryan, N. S., Turkheimer, F., de Llano, S. R. M., Edison, P., Douglas, J., Fox, N. C., Brooks, D. J., & Rossor, M. N. (2010) · Brain · doi:10.1093/brain/awq310 · Cited by 84 · see citing works

Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer ?-amyloid deposition

Yamaguchi, H., Ishiguro, K., Sugihara, S., Nakazato, Y., Kawarabayashi, T., Sun, X., & Hirai, S. (1994) · Acta Neuropathologica · doi:10.1007/bf00389492 · Cited by 72 · see citing works

Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation

Shinohara, M., Petersen, R. C., Dickson, D. W., & Bu, G. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1086-9 · Cited by 70 · see citing works

Localization of amyloid precursor protein in selective postsynaptic densities of rat cortical neurons

Shigematsu, K., McGeer, P. L., & McGeer, E. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)91697-d · Cited by 70 · see citing works

Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: An update

Larner, A. J., & Doran, M. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1042 · Cited by 67 · see citing works

Carbon 11–Labeled Pittsburgh Compound B Positron Emission Tomographic Amyloid Imaging in Patients With APP Locus Duplication

Remes, A. M., Laru, L., Tuominen, H. J., Aalto, S., Kemppainen, N. M., Mononen, H., Någren, K., Parkkola, R. K., & Rinne, J. O. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.540 · Cited by 63 · see citing works

C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic.

Wojtas, A., Heggeli, K., Finch, N. A., Baker, M. C., DeJesus‐Hernandez, M., Younkin, S. G., Dickson, D. W., Graff‐Radford, N. R., & Rademakers, R. (2012) · Europe PMC (PubMed Central) · Cited by 53 · see citing works

Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations

Lee, G. J., Lu, P. H., Medina, L. D., Rodríguez‐Agudelo, Y., Melchor, S. J., Coppola, G., Braskie, M. N., Hua, X., Apostolova, L. G., Leow, A., et al. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-302087 · Cited by 53 · see citing works

Striatal plasticity and extrapyramidal motor dysfunction

Chase, T. N. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.02.012 · Cited by 51 · see citing works

Specificity of mechanisms for plaque removal after Aβ immunotherapy for Alzheimer disease

Akiyama, H., & McGeer, P. L. (2004) · Nature Medicine · doi:10.1038/nm0204-117 · Cited by 51 · see citing works

Caudate Infarcts and Hemorrhages

Venti, M. P., Paciaroni, M., & Caso, V. (2012) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000333616 · Cited by 49 · see citing works

Alzheimer's Disease Families with Amyloid Precursor Protein Mutationsa

Rossor, M. N., Newman, S., Frackowiak, R. S. J., Lantos, P. L., & Kennedy, A. M. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23052.x · Cited by 46 · see citing works

Seizures and the basal ganglia: a review of the clinical data

Vercueil, L., & Hirsch, É. (2002) · Epileptic Disorders · doi:10.1684/j.1950-6945.2002.tb00545.x · Cited by 43 · see citing works

Relationship between apolipoprotein E and the amyloid deposits and dystrophic neurites of Alzheimer’s disease.

Dickson, T. C., Saunders, H. L., & Vickers, J. C. (1997) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1997.tb01325.x · Cited by 40 · see citing works

Biochemical, neuropathological, and neuroimaging characteristics of early-onset Alzheimer's disease due to a novel PSEN1 mutation

Ringman, J. M., Gylys, K. H., Medina, L. D., Fox, M., Kepe, V., Flores, D. L., Apostolova, L. G., Barrio, J. R., Small, G., Silverman, D. H. S., et al. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.039 · Cited by 34 · see citing works

A Quantitative and Immunohistochemical Study on Apolipoprotein E in Brain Tissue in Alzheimer’s Disease

Hesse, C., Bogdanović, N., Davidsson, P., & Blennow, K. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017189 · Cited by 26 · see citing works

Distribution of apolipoprotein E in senile plaques in brains with Alzheimer's disease: investigation with the confocal laser scan microscope

Nishiyama, E., Iwamoto, N., Ohwada, J., & Arai, H. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01329-7 · Cited by 18 · see citing works

Immunohistochemical detection of apolipoprotein E within prion-associated lesions in squirrel monkey brains

Nakamura, S., Ono, F., Hamano, M., Odagiri, K., Kubo, M., KOMATSUZAKI, K., Terao, K., Shinagawa, M., Takahashi, K., & Yoshikawa, Y. (2000) · Acta Neuropathologica · doi:10.1007/s004010000200 · Cited by 16 · see citing works

Brain regions and genes affecting myoclonus in animals

Lalonde, R., & Strazielle, C. (2012) · Neuroscience Research · doi:10.1016/j.neures.2012.07.004 · Cited by 13 · see citing works

Pick's disease: selective occurrence of apolipoprotein E-immunoreactive Pick bodies in the limbic system

Hayashi, S., Wakabayashi, K., Iwanaga, K., Kakita, A., Seki, K., Tanaka, M., Okuizumi, K., Onodera, O., Tanaka, H., Tsuji, S., et al. (1998) · Acta Neuropathologica · doi:10.1007/s004010050759 · Cited by 9 · see citing works

What Can We Learn From Regional Vulnerability to amyloid-β Accumulation in Nondemented individuals?

Shinohara, M., & Bu, G. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.20 · Cited by 2 · see citing works

Diagnostic criteria for primary progressive mutiple sclerosis: a position paper.

(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2 · see citing works

Alzheimer's disease: experimental models and reality

Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810 · see citing works

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

Rodriguez-Vieitez, E., Saint-Aubert, L., Carter, S. F., Almkvist, O., Farid, K. A., Schöll, M., Chiotis, K., Thordardottir, S., Graff, C., Wall, A., et al. (2016) · Brain : a journal of neurology · doi:10.1093/brain/awv404 · Cited by 285 · see citing works

Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies

Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297 · see citing works

The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer’s disease

Kanekiyo, T., & Bu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00093 · Cited by 281 · see citing works

Meta‐analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability

de Wilde, M. C., Overk, C., Sijben, J., & Masliah, E. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.12.005 · Cited by 273 · see citing works

Detection of subjects and brain regions related to Alzheimer's disease using 3D MRI scans based on eigenbrain and machine learning

Zhang, Y., Dong, Z., Phillips, P., Wang‎, S., Ji, G., Yang, J., & Yuan, T. (2015) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2015.00066 · Cited by 279 · see citing works

Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition

Liu, C.-C., Hu, J., Zhao, N., Wang, J., Wang, N., Cirrito, J. R., Kanekiyo, T., Holtzman, D. M., & Bu, G. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.3442-16.2017 · Cited by 267 · see citing works

Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease

Drummond, E., Nayak, S., Faustin, A., Pires, G., Hickman, R. A., Askenazi, M., Cohen, M., Haldiman, T., Kim, C., Han, X., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1691-0 · Cited by 239 · see citing works

Plant alkaloids as drug leads for Alzheimer's disease

Ng, Y. P., Or, T. C. T., & Ip, N. Y. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.07.018 · Cited by 236 · see citing works

Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina

Shi, H., Koronyo, Y., Rentsendorj, A., Regis, G. C., Sheyn, J., Fuchs, D.-T., Kramerov, A. A., Ljubimov, A. V., Dumitrascu, O. M., Rodriguez, A. R., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02134-w · Cited by 230 · see citing works

APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes

Zhao, J., Davis, M. D., Martens, Y. A., Shinohara, M., Graff-Radford, N. R., Younkin, S. G., Wszolek, Z. K., Kanekiyo, T., & Bu, G. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx155 · Cited by 221 · see citing works

Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression

Yamazaki, Y., Shinohara, M., Shinohara, M., Yamazaki, A., Murray, M. E., Liesinger, A. M., Heckman, M. G., Lesser, E. R., Parisi, J. E., Petersen, R. C., et al. (2019) · Brain · doi:10.1093/brain/awz011 · Cited by 202 · see citing works

Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia

Bereczki, E., Francis, P. T., Howlett, D., Pereira, J. B., Höglund, K., Bogstedt, A., Cedazo‐Minguez, A., Baek, J., Hortobágyi, T., Attems, J., et al. (2016) · Alzheimer's &amp; Dementia · doi:10.1016/j.jalz.2016.04.005 · Cited by 167 · see citing works

APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1

Tachibana, M., Holm, M.-L., Liu, C.-C., Shinohara, M., Aikawa, T., Oue, H., Yamazaki, Y., Martens, Y. A., Murray, M. E., Sullivan, P. M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124853 · Cited by 156 · see citing works

microRNA-34a-Mediated Down-Regulation of the Microglial-Enriched Triggering Receptor and Phagocytosis-Sensor TREM2 in Age-Related Macular Degeneration

Bhattacharjee, S., Zhao, Y., Dua, P., Rogaev, E. I., & Lukiw, W. J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150211 · Cited by 147 · see citing works

Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology

Grothe, M. J., Sepulcre, J., Gonzalez-Escamilla, G., Jelistratova, I., Schöll, M., Hansson, O., Teipel, S. J., & Initiative, A. D. N. (2018) · Brain · doi:10.1093/brain/awy189 · Cited by 142 · see citing works

From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation

Goulay, R., Romo, L. M., Hol, E. M., & Dijkhuizen, R. M. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00755-2 · Cited by 142 · see citing works

APOE ε2 is associated with increased tau pathology in primary tauopathy

Zhao, N., Liu, C.-C., Van Ingelgom, A. J., Linares, C., Kurti, A., Knight, J. A., Heckman, M. G., Diehl, N. N., Shinohara, M., Martens, Y. A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06783-0 · Cited by 139 · see citing works

Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain

Kurbatskaya, K., Phillips, E. C., Croft, C. L., Dentoni, G., Hughes, M. M., Wade, M. A., Al-Sarraj, S., Troakes, C., O'Neill, M., Perez-Nievas, B., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0299-2 · Cited by 132 · see citing works

Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer’s disease

Shinohara, M., Murray, M. E., Frank, R. D., Shinohara, M., DeTure, M., Yamazaki, Y., Tachibana, M., Atagi, Y., Davis, M. D., Liu, C.-C., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1580-y · Cited by 123 · see citing works

Zinc Finger Proteins in Neuro-Related Diseases Progression

Bu, S., Lv, Y., Liu, Y., Qiao, S., & Wang, H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.760567 · Cited by 107 · see citing works

Neuropathology of Autosomal Dominant Alzheimer Disease in the National Alzheimer Coordinating Center Database

Ringman, J. M., Monsell, S., Ng, D. W., Zhou, Y., Nguyen, A., Coppola, G., Van Berlo, V., Mendez, M. F., Tung, S., Weintraub, S., et al. (2016) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1093/jnen/nlv028 · Cited by 99 · see citing works

<i>APOE2</i> eases cognitive decline during Aging: Clinical and preclinical evaluations

Shinohara, M., Kanekiyo, T., Yang, L., Linthicum, D., Shinohara, M., Fu, Y., Price, L., Frisch‐Daiello, J. L., Han, X., Fryer, J. D., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24628 · Cited by 111 · see citing works

Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies

Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96 · see citing works

Traditional Ayurvedic and herbal remedies for Alzheimer’s disease: from bench to bedside

Sharma, R., Kuča, K., Nepovimová, E., Kabra, A., Rao, M. C., & Prajapati, P. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1596803 · Cited by 86 · see citing works

Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of A lzheimer's disease‐like pathology

Stefanova, N. A., Maksimova, K. Y., Владимировна, К. Е., Rudnitskaya, E. A., Muraleva, N. A., & Kolosova, N. G. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12248 · Cited by 85 · see citing works

Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability

Muratore, C., Zhou, C. Q., Liao, M., Fernandez, M. A., Taylor, W. M., Lagomarsino, V. N., Pearse, R. V., Rice, H. C., Negri, J. M., He, A., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.015 · Cited by 82 · see citing works

Early Life Stress and Epigenetics in Late-onset Alzheimer’s Dementia: A Systematic Review

Lemche, E. (2018) · Current Genomics · doi:10.2174/1389202919666171229145156 · Cited by 82 · see citing works

Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects

Loeffler, D. A. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230025 · Cited by 86 · see citing works

Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late‐onset amyloid deposition

Cohen, A. D., McDade, E., Christian, B. T., Price, J. C., Mathis, C. A., Klunk, W. E., & Handen, B. L. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.002 · Cited by 78 · see citing works

An antioxidant specifically targeting mitochondria delays progression of Alzheimer’s disease-like pathology

Stefanova, N. A., Muraleva, N. A., Maksimova, K. Y., Rudnitskaya, E. A., Владимировна, К. Е., Telegina, D. V., & Kolosova, N. G. (2016) · Aging · doi:10.18632/aging.101054 · Cited by 77 · see citing works

Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome

Bejanin, A., Iulita, M. F., Vilaplana, E., Carmona-Iragui, M., Benejam, B., Videla, L., Barroeta, I., Fernandez, S., Altuna, M., Pegueroles, J., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.1893 · Cited by 76 · see citing works

Identification of proteins that are differentially expressed in brains with Alzheimer's disease using iTRAQ labeling and tandem mass spectrometry

Minjarez, B. D., Calderón-González, K. G., Rustarazo, M. L. V., Herrera-Aguirre, M. E., Labra‐Barrios, M. L., Rincón-Limas, D. E., del Pino, M. M. S., Mena, R., & Luna‐Arias, J. P. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2016.03.022 · Cited by 75 · see citing works

Visualization of regional tau deposits using 3H-THK5117 in Alzheimer brain tissue

Lemoine, L., Saint‐Aubert, L., Marutle, A., Antoni, G., Eriksson, J., Ghetti, B. F., Okamura, N., Nennesmo, I., Gillberg, P.-G., & Nordberg, A. K. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0220-4 · Cited by 65 · see citing works

The Implications of Angiotensin-Converting Enzymes and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives

Kaur, P., Muthuraman, A., & Kaur, M. (2015) · ACS Chemical Neuroscience · doi:10.1021/cn500363g · Cited by 63 · see citing works

The Role of KLF4 in Alzheimer’s Disease

Cheng, Z., Zou, X., Jin, Y., Gao, S., Lv, J., Li, B., & Cui, R. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00325 · Cited by 63 · see citing works

Neurogranin as a Novel Biomarker in Alzheimer’s Disease

Agnello, L., Gambino, C. M., Sasso, B. L., Bivona, G., Milano, S., Ciaccio, A. M., Piccoli, T., Bella, V. L., & Ciaccio, M. (2020) · Laboratory Medicine · doi:10.1093/labmed/lmaa062 · Cited by 61 · see citing works

Three-Dimensional Eigenbrain for the Detection of Subjects and Brain Regions Related with Alzheimer’s Disease

Zhang, Y., Wang‎, S., Phillips, P., Yang, J., & Yuan, T. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150988 · Cited by 58 · see citing works

Synaptic Loss, ER Stress and Neuro-Inflammation Emerge Late in the Lateral Temporal Cortex and Associate with Progressive Tau Pathology in Alzheimer’s Disease

Buchanan, H. M., Mackay, M., PALMER, K., Tothová, K., Katsur, M., Platt, B., & Koss, D. J. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01950-1 · Cited by 55 · see citing works

5-Caffeoylquinic Acid Ameliorates Cognitive Decline and Reduces Aβ Deposition by Modulating Aβ Clearance Pathways in APP/PS2 Transgenic Mice

Ishida, K., Misawa, K., Nishimura, H., Hirata, T., Yamamoto, M., & Ota, N. (2020) · Nutrients · doi:10.3390/nu12020494 · Cited by 53 · see citing works

Chronic low-dose-rate ionising radiation affects the hippocampal phosphoproteome in the ApoE−/− Alzheimer's mouse model

Kempf, S. J., Janik, D., Barjaktarović, Ž., Braga-Tanaka, I., Tanaka, S., Neff, F., Saran, A., Larsen, M. R., & Tapio, S. (2016) · Oncotarget · doi:10.18632/oncotarget.12376 · Cited by 47 · see citing works

Clinical, pathophysiological and genetic features of motor symptoms in autosomal dominant Alzheimer’s disease

Vöglein, J., Paumier, K. L., Jucker, M., Preische, O., McDade, E., Hassenstab, J. J., Benzinger, T. L. S., Noble, J. M., Berman, S. B., Graff‐Radford, N. R., et al. (2019) · Brain · doi:10.1093/brain/awz050 · Cited by 46 · see citing works

Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease

Alcendor, D. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051490 · Cited by 46 · see citing works

Silencing of LRP1 Exacerbates Inflammatory Response Via TLR4/NF-κB/MAPKs Signaling Pathways in APP/PS1 Transgenic Mice

He, Y., Ruganzu, J. B., Zheng, Q., Wu, X., Jin, H., Peng, X., Ding, B., Lin, C., Ji, S., Ma, Y., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01982-7 · Cited by 45 · see citing works

In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer’s Brain Tissue

Ni, R., Röjdner, J., Voytenko, L., Dyrks, T., Thiele, A., Marutle, A., & Nordberg, A. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-201344 · Cited by 35 · see citing works

Fungicide Residues Exposure and β-amyloid Aggregation in a Mouse Model of Alzheimer’s Disease

Lafon, P., Wang, Y., Arango-Lievano, M., Torrent, J., Salvador-Prince, L., Mansuy, M., Mestre‐Francés, N., Givalois, L., Liu, J., Mercader, J. V., et al. (2020) · Environmental Health Perspectives · doi:10.1289/ehp5550 · Cited by 43 · see citing works

Impairment of the nerve growth factor pathway driving amyloid accumulation in cholinergic neurons: the incipit of the Alzheimer′s disease story?

Triaca, V., & Calissano, P. (2016) · Neural Regeneration Research · doi:10.4103/1673-5374.193224 · Cited by 40 · see citing works

Plaque-Associated Oligomeric Amyloid-Beta Drives Early Synaptotoxicity in APP/PS1 Mice Hippocampus: Ultrastructural Pathology Analysis

Sanchez-Varo, R. M., Sánchez‐Mejías, E., Fernandez-Valenzuela, J. J., Castro, V. D., Mejias‐Ortega, M., Gómez-Arboledas, Á., Jiménez, S., Sanchez-Mico, M. V., Trujillo‐Estrada, L., Moreno‐González, I., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.752594 · Cited by 38 · see citing works

Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease

Liu, H., Kim, C., Haldiman, T., Sigurdson, C. J., Nyström, S., Nilsson, K. P. R., Cohen, M. L., Wısnıewskı, T., Hammarström, P., & Safar, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101267 · Cited by 38 · see citing works

Molecular and cellular mechanisms of sporadic Alzheimer’s disease: Studies on rodent models in vivo

Gulyaeva, N. V., Bobkova, N. V., Kolosova, N. G., Samokhin, A. N., Stepanichev, M. Y., & Stefanova, N. A. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917100029 · Cited by 37 · see citing works

Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle

Mattson, M. P. (2015) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2015.3 · Cited by 34 · see citing works

Blood–Brain Barrier ( BBB ) Dysfunction in CNS Diseases: Paying Attention to Pericytes

Yu, T., Wang, Z., Chen, Y., Xiang, Y., Wu, M., Zhang, M., Yin, X., & Chen, Z. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70422 · Cited by 36 · see citing works

Identification of plexin A4 as a novel clusterin receptor links two Alzheimer’s disease risk genes

Kang, S. S., Kurti, A., Wojtas, A., Baker, K. E., Liu, C., Kanekiyo, T., Deming, Y. K., Cruchaga, C., Estus, S., Bu, G., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw188 · Cited by 33 · see citing works

Hippocampal synaptic failure is an early event in experimental parkinsonism with subtle cognitive deficit

Belloso-Iguerategui, A., Zamarbide, M., Merino-Galán, L., Rodríguez-Chinchilla, T., Gago, B., Santamaría, E., Fernández‐Irigoyen, J., Cotman, C. W., Prieto, G. A., Quiroga‐Varela, A., et al. (2023) · Brain · doi:10.1093/brain/awad227 · Cited by 33 · see citing works

PET/CT of Dementia

Zukotynski, K., Kuo, P. H., Mikulis, D. J., Rosa‐Neto, P., Strafella, A. P., Subramaniam, R. M., & Black, S. E. (2018) · American Journal of Roentgenology · doi:10.2214/ajr.18.19822 · Cited by 30 · see citing works

The current landscape in Alzheimer’s disease research and drug discovery

Devenish, S. R. A. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.04.002 · Cited by 28 · see citing works

Shenzhiling oral solution promotes myelin repair through PI3K/Akt-mTOR pathway in STZ-induced SAD mice

Qin, G., Wang, Y., Liu, Z., Mana, L., Huang, S., & Wang, P. (2021) · 3 Biotech · doi:10.1007/s13205-021-02900-x · Cited by 27 · see citing works

Characterization of the effects of calcitonin gene-related peptide receptor antagonist for Alzheimer's disease

Na, H., Gan, Q., Mcparland, L., Yang, J. B., Yao, H., Tian, H., Zhang, Z., & Qiu, W. Q. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108017 · Cited by 26 · see citing works

Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice

Meco, A. D., Joshi, Y. B., Lauretti, E., & Praticò, D. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.78 · Cited by 26 · see citing works

Lower functional connectivity of default mode network in cognitively normal young adults with mutation of APP, presenilins and APOE ε4

Su, Y. Y., Zhang, X. D., Schoepf, U. J., Varga‐Szemes, Á., Stubenrauch, A. C., Liang, X., Zheng, L. J., Zheng, G., Kong, X., Xu, Q., et al. (2016) · Brain Imaging and Behavior · doi:10.1007/s11682-016-9556-z · Cited by 25 · see citing works

Relationship between single nucleotide polymorphisms in the 3′UTR of amyloid precursor protein and risk of Alzheimer’s disease and its mechanism

Zhou, Q., Luo, L., Wang, X., & Li, X. (2019) · Bioscience Reports · doi:10.1042/bsr20182485 · Cited by 25 · see citing works

Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer’s disease

Shinohara, M., Koga, S., Konno, T., Nix, J., Shinohara, M., Aoki, N., Das, P., Parisi, J. E., Petersen, R. C., Rosenberry, T. L., et al. (2017) · Brain · doi:10.1093/brain/awx284 · Cited by 24 · see citing works

5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway

Shinohara, M., Shinohara, M., Zhao, J., Fu, Y., Liu, C., Kanekiyo, T., & Bu, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061488 · Cited by 24 · see citing works

The Structure and Function of α, β and γ-Secretase as Therapeutic Target Enzymes in the Development of Alzheimer’s Disease: A Review

Ahmad, S. S., Khan, S. M., Kamal, M. A., & Wasi, U. (2019) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527318666191011145941 · Cited by 23 · see citing works

Understanding the Role of the BAI Subfamily of Adhesion G Protein-Coupled Receptors (GPCRs) in Pathological and Physiological Conditions

Moon, S. Y., Shin, S.-A., Oh, Y., Park, H. H., & Lee, C. S. (2018) · Genes · doi:10.3390/genes9120597 · Cited by 21 · see citing works

Acute restraint stress reverses impaired LTP in the hippocampal CA1 region in mouse models of Alzheimer’s disease

Wang, M., Ramasamy, V. S., Samidurai, M., & Jo, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-47452-6 · Cited by 22 · see citing works

Frontal-subcortical behaviors during Alzheimer's disease in individuals with Down syndrome

Fonseca, L. M., Mattar, G. P., Haddad, G. G., Gonçalves, A. S., Miguel, A. C., Guilhoto, L. M. D. F. F., Zaman, S. H., Holland, A. J., Bottino, C. M. D. C., & Hoexter, M. Q. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.02.028 · Cited by 21 · see citing works

Increased levels of Aβ42 decrease the lifespan of ob/ob mice with dysregulation of microglia and astrocytes

Shinohara, M., Tashiro, Y., Shinohara, M., Hirokawa, J., Suzuki, K., Onishi‐Takeya, M., Mukouzono, M., Takeda, S., Saito, T., Fukumori, A., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201901028rr · Cited by 21 · see citing works

Comparison of longitudinal Aβ in nondemented elderly and Down syndrome

Tudorascu, D., Anderson, S., Minhas, D. S., Yu, Z., COMER, D. M., Lao, P. J., Hartley, S. L., Laymon, C. M., Snitz, B. E., Lopresti, B. J., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.030 · Cited by 20 · see citing works

Altered structural and functional homotopic connectivity associated with the progression from mild cognitive impairment to Alzheimer's disease

Chen, S., Wu, H., Song, Y., Ge, H., Yan, Z., Xue, C., Qi, W., Yuan, Q., Lin, X., & Chen, J. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.115000 · Cited by 20 · see citing works

The Use of Random Forests to Classify Amyloid Brain PET

Zukotynski, K., Gaudet, V., Kuo, P. H., Adamo, S. M., Goubran, M., Scott, C. J. M., Bocti, C., BORRIE, M. J., Chertkow, H. M., Frayne, R., et al. (2019) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002747 · Cited by 19 · see citing works

Understanding the complex interplay between tau, amyloid and the network in the spatiotemporal progression of Alzheimer’s disease

Raj, A., Torok, J., & Ranasinghe, K. G. (2025) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2025.102750 · Cited by 19 · see citing works

Which neuroimaging and fluid biomarkers method is better in theranostic of Alzheimer’s disease? An umbrella review

Mohammadi, H., Ariaei, A., Ghobadi, Z., Gorgich, E. A. C., & Rustamzadeh, A. (2024) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2024.02.007 · Cited by 18 · see citing works

Aerobic Exercise Facilitates the Nuclear Translocation of SREBP2 by Activating AKT/SEC24D to Contribute Cholesterol Homeostasis for Improving Cognition in APP/PS1 Mice

Hu, Z., Yuan, Y.-Q., Tong, Z., Liao, M., Yuan, S., Wu, W., Tang, Y., Wang, Y., Tang, C., & Liu, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612847 · Cited by 17 · see citing works

Isobavachalcone ameliorates cognitive deficits, and Aβ and tau pathologies in triple-transgenic mice with Alzheimer's disease

Zhang, M., Wu, Q., Zhao, R., Yao, X., Du, X., Liu, Q., Lv, G., & Xiao, S. (2021) · Food & Function · doi:10.1039/d1fo01306h · Cited by 16 · see citing works

Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Is Not a Major Determining Factor in the Development of Sporadic Alzheimer Disease: Evidence from an Updated Meta-Analysis

Wang, X.-B., Cui, N.-H., Yang, J., Qiu, X.-P., Gao, J.-J., Yang, N., & Zheng, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111406 · Cited by 15 · see citing works

ELISA Evaluation of Tau Accumulation in the Brains of Patients with Alzheimer Disease

Shinohara, M., Hirokawa, J., Shimodaira, A., Tashiro, Y., Suzuki, K., Gheni, G., Fukumori, A., Matsubara, T., Morishima, M., Saito, Y., et al. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab047 · Cited by 14 · see citing works

The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score

Zukotynski, K., Gaudet, V., Kuo, P. H., Adamo, S. M., Goubran, M., Scott, C. J. M., Bocti, C., BORRIE, M. J., Chertkow, H. M., Frayne, R., et al. (2020) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000003043 · Cited by 14 · see citing works

Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer’s disease

Levitis, E., Vogel, J. W., Funck, T., Hachinski, V., Gauthier, S. G., Vöglein, J., Levin, J., Gordon, B. A., Benzinger, T. L. S., Iturria‐Medina, Y., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac085 · Cited by 13 · see citing works

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study

O’Connor, A., Cash, D. M., Poole, T., Markiewicz, P. J., Fraser, M. R., Malone, I. B., Jiao, J., Weston, P. S. J., Flores, S. E., Hornbeck, R. C., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01234-5 · Cited by 14 · see citing works

Mammalian Models in Alzheimer’s Research: An Update

Sharma, H., Chang, K., Hulme, J., & An, S. S. A. (2023) · Cells · doi:10.3390/cells12202459 · Cited by 11 · see citing works

Familial Alzheimer’s Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants

Wojsiat, J., Laskowska-Kaszub, K., Alquézar, C., Białopiotrowicz, E., Esteras, N., Zdioruk, M. I., Martín‐Requero, Á., & Wojda, U. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0105-y · Cited by 12 · see citing works

Role of Lipid Peroxidation Process in Neurodegenerative Disorders

Muthuraman, A., Rishitha, N., Paramakrishnan, N., Bhaskaran, M., & Ramesh, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81188 · Cited by 12 · see citing works

Unraveling the Role of LRP1 in Alzheimer’s Disease: A Focus on Aβ Clearance and the Liver-Brain Axis

Yang, W., Wei, Z., & Wang, T. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02339-2 · Cited by 14 · see citing works

Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems

Loeffler, D. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240212 · Cited by 12 · see citing works

A Case Report of a 37-Year-Old Alzheimer's Disease Patient with Prominent Striatum Amyloid Retention

Um, Y. H., Choi, W. H., Jung, W. S., Park, Y. H., Lee, C. U., & Lim, H. K. (2017) · Psychiatry Investigation · doi:10.4306/pi.2017.14.4.521 · Cited by 11 · see citing works

Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer’s disease

Iaccarino, L., Llibre‐Guerra, J. J., McDade, E., Edwards, L., Gordon, B. A., Benzinger, T. L. S., Hassenstab, J. J., Kramer, J. H., Li, Y., Miller, B. L., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae159 · Cited by 10 · see citing works

Electroacupuncture regulates Rab5a‐mediating NGF transduction to improve learning and memory ability in the early stage of AD mice

Li, J., Yang, M., Dai, Y., Guo, X., Ding, Y., Li, X., Zhang, S., Xu, W., Chen, L., Tao, J., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14743 · Cited by 10 · see citing works

Beta Amyloid Peptides: Extracellular and Intracellular Mechanisms of Clearance in Alzheimer’s Disease

Hernández-Zimbrón, L. F., Gorostieta-Salas, E., Díaz-Hung, M.-L., Pérez-Garmendia, R., Gevorkian, G., & Quiroz-Mercado, H. (2016) · InTech eBooks · doi:10.5772/64744 · Cited by 10 · see citing works

Upregulated expression of a subset of genes in APP;ob/ob mice: Evidence of an interaction between diabetes‐linked obesity and Alzheimer’s disease

Shinohara, M., Kikuchi, M., Onishi‐Takeya, M., Tashiro, Y., Suzuki, K., Noda, Y., Takeda, S., Mukouzono, M., Nagano, S., Fukumori, A., et al. (2021) · FASEB BioAdvances · doi:10.1096/fba.2020-00151 · Cited by 9 · see citing works

Alterations of Spontaneous Cortical and Subcortical Activity in Type 2 Diabetes Mellitus with and without Depression

Tian, J., Liu, R., Li, Z.-L., Tan, J., Lu, Y., Zhang, W., Liu, J., Gong, R., Cao, J., Yang, C. D., et al. (2023) · Neuroendocrinology · doi:10.1159/000529055 · Cited by 9 · see citing works

Effects of Amylin Against Amyloid-β-Induced Tauopathy and Synapse Loss in Primary Neurons

Gan, Q., Yao, H., Na, H., Ballance, H. I., Tao, Q., Leung, L., Tian, H., Zhu, H., Wolozin, B. L., & Qiu, W. Q. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190161 · Cited by 9 · see citing works

Intraperitoneal Administration of Monoclonal Antibody Against Pathologic Aβ 42 Aggregates Alleviated Cognitive Deficits and Synaptic Lesions in APP/PS1 Mice

Xiao, S., Song, L., Li, J., Wang, H., Yu, N., Wang, Z., Zhang, Y., He, J., & Hung, T. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190874 · Cited by 9 · see citing works

Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer’s Disease: A Two-Sample Mendelian Randomization Study

Kim, S., Kim, K., Nho, K. T., Myung, W., & Won, H. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-200671 · Cited by 7 · see citing works

Detection of early Alzheimer's disease‐like molecular alterations in a mouse model expressing human ApoE4

Rai, A., Ojiakor, O. A., & Rylett, R. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15904 · Cited by 6 · see citing works

Association between striatal amyloid deposition and motor prognosis in Parkinson's disease

Park, M., Kim, H. J., Baik, K., Na, H. K., Lee, Y., Yoon, S. H., Jeong, S. H., Chung, S. J., Shin, H., Lyoo, C. H., et al. (2024) · European Journal of Neurology · doi:10.1111/ene.16364 · Cited by 6 · see citing works

Phenotypic Variability in Autosomal Dominant Familial Alzheimer Disease due to the S170F Mutation of Presenilin-1

Tiedt, H. O., Benjamin, B., Niedeggen, M., & Lueschow, A. (2018) · Neurodegenerative Diseases · doi:10.1159/000485899 · Cited by 6 · see citing works

Probing the Role of a Regional Quantitative Assessment of Amyloid PET

Peira, E., Grazzini, M., Bauckneht, M., Sensi, F., Bosco, P., Arnaldi, D., Morbelli, S. D., Chincarini, A., Pardini, M., & Nobili, F. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201156 · Cited by 5 · see citing works

Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease

Kim, K. W., Kwon, H., Kim, Y.-E., Yoon, C. W., Kim, Y. J., Kim, Y. B., Lee, J. M., Yoon, W. T., Kim, Y. J., Lee, J. S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-36580-0 · Cited by 5 · see citing works

Changes in the transcriptome of the prefrontal cortex of OXYS rats as signs of the development of Alzheimer’s disease

Stefanova, N. A., Korbolina, E. E., Ershov, N., Rogaev, E. I., & Kolosova, N. G. (2016) · Russian Journal of Genetics Applied Research · doi:10.1134/s2079059716040195 · Cited by 4 · see citing works

A JOURNAL OF NEUROLOGY

Graff‐Radford, N. R., Petersen, R. C., Dickson, D. W., & Bu, G. (2016)

P1‐334: Regional Distribution of Amyloid‐Beta, Soluble App and Synaptic Markers in Human Brains

Shinohara, M., Dickson, D. W., & Bu, G. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.06.1085

Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val→Ile) mutation cases: A morphometric investigation

Fukutani, Y., Cairns, N. J., Rossor, M. N., & Lantos, P. L. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)05399-9 · Cited by 41 · see citing works

Variability in the type and layer distribution of cortical A beta pathology in familial Alzheimer's disease

Willumsen, N., Poole, T., Nicholas, J., Fox, N., Ryan, N., & Lashley, T. (2021) · UCL Discovery (University College London)

Comparison of Aβ levels in the brain of familial and sporadic Alzheimer's disease

Hellström‐Lindahl, E., Viitanen, M. H., & Marutle, A. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.03.007 · Cited by 75 · see citing works